(STM) STMicroelectronics - Overview
Stock: Microcontrollers, Sensors, Power Semiconductors, Analog Ics
| Risk 5d forecast | |
|---|---|
| Volatility | 48.2% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.87 |
| Alpha | 26.45 |
| Character TTM | |
|---|---|
| Beta | 1.862 |
| Beta Downside | 1.883 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.66% |
| CAGR/Max DD | -0.17 |
EPS (Earnings per Share)
Revenue
Description: STM STMicroelectronics February 11, 2026
STMicroelectronics N.V. (NYSE: STM) designs, develops, manufactures, and sells a broad portfolio of semiconductor products across four primary segments: Analog-MEMS-Sensors (AM&S), Power & Discrete (P&D), Microcontrollers (MCU), and Digital ICs & RF (D&RF). Its catalogue spans industrial ASICs/ASSPs, power-management ICs, custom analog solutions, wireless-charging chips, MEMS sensors (accelerometers, gyroscopes, magnetic, pressure, temperature, biosensors), edge-AI smart sensors, SiC MOSFETs, IGBTs, automotive MCUs, NFC, and RF communication components, serving automotive, industrial, consumer electronics, communications equipment, and computing markets.
In the most recent quarter (Q3 2024), STM reported revenue of $2.84 billion, up 12 % YoY, driven primarily by a 45 % contribution from the automotive segment and a 30 % year-over-year rise in its MEMS-sensor sales, reflecting accelerating demand for electric-vehicle power electronics and edge-AI applications. The company’s gross margin expanded to 38.5 % versus 36.2 % a year earlier, benefitting from higher SiC MOSFET shipments and a favorable product mix in the Power & Discrete business. Macro-level drivers include the global shift toward EVs (projected to reach 30 % of new car sales by 2030) and the ongoing need for energy-efficient power solutions in data-center and industrial automation, both of which align with STM’s core product lines.
For a data-driven valuation framework, the ValueRay model offers a granular view of STM’s upside and downside scenarios.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 163.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.60 > 1.0 |
| NWC/Revenue: 66.99% < 20% (prev 59.99%; Δ 7.00% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.16b > Net Income 163.8m |
| Net Debt (-704.0m) to EBITDA (2.27b): -0.31 < 3 |
| Current Ratio: 3.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.00b) vs 12m ago 6.87% < -2% |
| Gross Margin: 33.77% > 18% (prev 0.39%; Δ 3338 % > 0.5%) |
| Asset Turnover: 47.72% > 50% (prev 53.63%; Δ -5.91% > 0%) |
| Interest Coverage Ratio: 9.77 > 6 (EBITDA TTM 2.27b / Interest Expense TTM 42.2m) |
Altman Z'' 6.35
| A: 0.32 (Total Current Assets 11.27b - Total Current Liabilities 3.35b) / Total Assets 24.80b |
| B: 0.53 (Retained Earnings 13.08b / Total Assets 24.80b) |
| C: 0.02 (EBIT TTM 412.4m / Avg Total Assets 24.77b) |
| D: 2.31 (Book Value of Equity 15.18b / Total Liabilities 6.58b) |
| Altman-Z'' Score: 6.35 = AAA |
Beneish M -3.11
| DSRI: 0.80 (Receivables 1.75b/2.44b, Revenue 11.82b/13.27b) |
| GMI: 1.17 (GM 33.77% / 39.34%) |
| AQI: 1.16 (AQ_t 0.10 / AQ_t-1 0.09) |
| SGI: 0.89 (Revenue 11.82b / 13.27b) |
| TATA: -0.08 (NI 163.8m - CFO 2.16b) / TA 24.80b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of STM shares?
Over the past week, the price has changed by +15.98%, over one month by +18.55%, over three months by +40.52% and over the past year by +44.82%.
Is STM a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the STM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | -1% |
| Analysts Target Price | 33.3 | -1% |
| ValueRay Target Price | 37.3 | 11% |
STM Fundamental Data Overview February 13, 2026
P/E Forward = 36.7647
P/S = 2.6748
P/B = 1.7423
P/EG = 0.4926
Revenue TTM = 11.82b USD
EBIT TTM = 412.4m USD
EBITDA TTM = 2.27b USD
Long Term Debt = 1.91b USD (from longTermDebt, two quarters ago)
Short Term Debt = 298.0m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -704.0m USD (from netDebt column, last quarter)
Enterprise Value = 28.77b USD (31.56b + Debt 2.13b - CCE 4.92b)
Interest Coverage Ratio = 9.77 (Ebit TTM 412.4m / Interest Expense TTM 42.2m)
EV/FCF = 271.0x (Enterprise Value 28.77b / FCF TTM 106.2m)
FCF Yield = 0.37% (FCF TTM 106.2m / Enterprise Value 28.77b)
FCF Margin = 0.90% (FCF TTM 106.2m / Revenue TTM 11.82b)
Net Margin = 1.39% (Net Income TTM 163.8m / Revenue TTM 11.82b)
Gross Margin = 33.77% ((Revenue TTM 11.82b - Cost of Revenue TTM 7.83b) / Revenue TTM)
Gross Margin QoQ = 35.21% (prev 33.23%)
Tobins Q-Ratio = 1.16 (Enterprise Value 28.77b / Total Assets 24.80b)
Interest Expense / Debt = 0.61% (Interest Expense 13.0m / Debt 2.13b)
Taxrate = 21.0% (US default 21%)
NOPAT = 325.8m (EBIT 412.4m * (1 - 21.00%))
Current Ratio = 3.36 (Total Current Assets 11.27b / Total Current Liabilities 3.35b)
Debt / Equity = 0.12 (Debt 2.13b / totalStockholderEquity, last quarter 17.83b)
Debt / EBITDA = -0.31 (Net Debt -704.0m / EBITDA 2.27b)
Debt / FCF = -6.63 (Net Debt -704.0m / FCF TTM 106.2m)
Total Stockholder Equity = 18.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.66% (Net Income 163.8m / Total Assets 24.80b)
RoE = 0.91% (Net Income TTM 163.8m / Total Stockholder Equity 18.06b)
RoCE = 2.07% (EBIT 412.4m / Capital Employed (Equity 18.06b + L.T.Debt 1.91b))
RoIC = 1.59% (NOPAT 325.8m / Invested Capital 20.45b)
WACC = 12.00% (E(31.56b)/V(33.70b) * Re(12.78%) + D(2.13b)/V(33.70b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 12.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.98%
[DCF Debug] Terminal Value 54.60% ; FCFF base≈165.7m ; Y1≈108.8m ; Y5≈49.6m
Fair Price DCF = 1.45 (EV 583.2m - Net Debt -704.0m = Equity 1.29b / Shares 888.8m; r=12.00% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -85.49 | EPS CAGR: -49.88% | SUE: -3.49 | # QB: 0
Revenue Correlation: -70.45 | Revenue CAGR: -1.69% | SUE: 0.20 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.17 | Chg30d=+0.031 | Revisions Net=+3 | Analysts=6
EPS next Year (2027-12-31): EPS=1.82 | Chg30d=-0.040 | Revisions Net=-1 | Growth EPS=+58.5% | Growth Revenue=+11.6%